Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biochemical and Biophysical Research Communications
|
January 17, 2008
Neuroglobin: enzymatic reduction and oxygen affinity
Alessandro Giuffrè, Tommaso Moschetti, Beatrice Vallone, et al.
Biophysical Journal
|
September 16, 2009
The structure of neuroglobin at high Xe and Kr pressure reveals partial conservation of globin internal cavities
Tommaso Moschetti, Uwe Mueller, Jörg Schulze, et al.
Protein Engineering, Design & Selection : PEDS
|
April 27, 2017
Development of a multipurpose scaffold for the display of peptide loops
Maxim Rossmann, Sandra J Greive, Tommaso Moschetti, et al.
Biochemical and Biophysical Research Communications
|
September 29, 2009
Failure of apoptosis-inducing factor to act as neuroglobin reductase
Tommaso Moschetti, Alessandro Giuffrè, Chiara Ardiccioni, et al.
The Journal of Biological Chemistry
|
October 30, 2009
Glyphosate resistance by engineering the flavoenzyme glycine oxidase
Mattia Pedotti, Elena Rosini, Gianluca Molla, et al.
Archives of Biochemistry and Biophysics
|
April 15, 2008
An X-ray diffraction and X-ray absorption spectroscopy joint study of neuroglobin
Alessandro Arcovito, Tommaso Moschetti, Paola D'Angelo, et al.
The EMBO Journal
|
March 7, 2018
Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA
Ineke Brouwer, Tommaso Moschetti, Andrea Candelli, et al.
Analytical Chemistry
|
February 15, 2017
Quantitative Affinity Determination by Fluorescence Anisotropy Measurements of Individual Nanoliter Droplets
Fabrice Gielen, Maren Butz, Eric J Rees, et al.
Journal of Molecular Biology
|
October 12, 2016
Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51
Tommaso Moschetti, Timothy Sharpe, Gerhard Fischer, et al.
Journal of Medicinal Chemistry
|
August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic Agents
Simon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biochemical and Biophysical Research Communications
|
January 17, 2008
Neuroglobin: enzymatic reduction and oxygen affinity
Alessandro Giuffrè, Tommaso Moschetti, Beatrice Vallone, et al.
Biophysical Journal
|
September 16, 2009
The structure of neuroglobin at high Xe and Kr pressure reveals partial conservation of globin internal cavities
Tommaso Moschetti, Uwe Mueller, Jörg Schulze, et al.
Protein Engineering, Design & Selection : PEDS
|
April 27, 2017
Development of a multipurpose scaffold for the display of peptide loops
Maxim Rossmann, Sandra J Greive, Tommaso Moschetti, et al.
Biochemical and Biophysical Research Communications
|
September 29, 2009
Failure of apoptosis-inducing factor to act as neuroglobin reductase
Tommaso Moschetti, Alessandro Giuffrè, Chiara Ardiccioni, et al.
The Journal of Biological Chemistry
|
October 30, 2009
Glyphosate resistance by engineering the flavoenzyme glycine oxidase
Mattia Pedotti, Elena Rosini, Gianluca Molla, et al.
Archives of Biochemistry and Biophysics
|
April 15, 2008
An X-ray diffraction and X-ray absorption spectroscopy joint study of neuroglobin
Alessandro Arcovito, Tommaso Moschetti, Paola D'Angelo, et al.
The EMBO Journal
|
March 7, 2018
Two distinct conformational states define the interaction of human RAD51-ATP with single-stranded DNA
Ineke Brouwer, Tommaso Moschetti, Andrea Candelli, et al.
Analytical Chemistry
|
February 15, 2017
Quantitative Affinity Determination by Fluorescence Anisotropy Measurements of Individual Nanoliter Droplets
Fabrice Gielen, Maren Butz, Eric J Rees, et al.
Journal of Molecular Biology
|
October 12, 2016
Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51
Tommaso Moschetti, Timothy Sharpe, Gerhard Fischer, et al.
Journal of Medicinal Chemistry
|
August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic Agents
Simon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
Page
of 2